F. Pisani et al., SINGLE-DOSE PHARMACOKINETICS OF CARBAMAZEPINE-10,11-EPOXIDE IN PATIENTS ON LAMOTRIGINE MONOTHERAPY, Epilepsy research, 19(3), 1994, pp. 245-248
The pharmacokinetics of a single oral dose of carbamazepine-10,11-epox
ide (CBZ-E, 100 mg) were compared in 10 patients on chronic monotherap
y with lamotrigine (LTG, 200-300 mg/day) and in 10 drug-free healthy c
ontrol subjects. CBZ-E pharmacokinetic parameters in LTG-treated patie
nts were found to be similar to those observed in controls (half-life:
7.2 +/- 1.6 vs 6.1 +/- 0.9 h; apparent oral clearance: 110.8 +/- 53.1
vs 120.5 +/- 29.9 ml/h/kg; apparent volume of distribution: 1.08 +/-
0.37 vs 1.04 +/- 0.25 l/kg respectively; means +/- s.d.). These data i
ndicate that, contrary to previous suggestions, LTG has no effect on t
he metabolic disposition of CBZ-E.